• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质母细胞瘤的CUSA液体蛋白质谱分析:肿瘤核心区与周边区的比较研究

Glioblastoma CUSA Fluid Protein Profiling: A Comparative Investigation of the Core and Peripheral Tumor Zones.

作者信息

La Rocca Giuseppe La, Simboli Giorgia Antonia, Vincenzoni Federica, Rossetti Diana Valeria, Urbani Andrea, Ius Tamara, Della Pepa Giuseppe Maria, Olivi Alessandro, Sabatino Giovanni, Desiderio Claudia

机构信息

Department of Neurosurgery, Mater Olbia Hospital, 07026 Olbia, Italy.

Institute of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University, 00168 Rome, Italy.

出版信息

Cancers (Basel). 2020 Dec 23;13(1):30. doi: 10.3390/cancers13010030.

DOI:10.3390/cancers13010030
PMID:33374813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7795841/
Abstract

The present investigation aimed to characterize the protein profile of cavitating ultrasound aspirator fluid of newly diagnosed and recurrent glioblastoma comparing diverse zones of collection, i.e., tumor core and tumor periphery, with the aid of 5-aminolevulinic acid fluorescence. The samples were pooled and analyzed in triplicate by LC-MS following the shotgun proteomic approach. The identified proteins were then grouped to disclose elements exclusive and common to the tumor state or tumor zones and submitted to gene ontology classification and pathway overrepresentation analysis. The proteins common to the distinct zones were further investigated by relative quantitation, following a label free approach, to disclose possible differences of expression. Nine proteins, i.e., tubulin 2B chain, CD59, far upstream element-binding, CD44, histone H1.4, caldesmon, osteopontin, tropomyosin chain and metallothionein-2, marked the core of newly diagnosed glioblastoma with respect to tumor periphery. Considering the tumor zone, including the core and the fluorescence positive periphery, the serine glycine biosynthesis, pentose phosphate, 5-hydroxytryptamine degredation, de novo purine biosynthesis and huntington disease pathways resulted statistically significantly overrepresented with respect to the human genome of reference. The fluorescence negative zone shared several protein elements with the tumor zone, possibly indicating the presence of pathological aspects of glioblastoma rather than of normal brain parenchyma. On the other hand, its exclusive protein elements were considered to represent the healthy zone and, accordingly, exhibiting no pathways overrepresentation. On the contrary to newly diagnosed glioblastoma, pathway overrepresentation was recognized only in the healthy zone of recurrent glioblastoma. The TGFβ signaling pathway, exclusively classified in the fluorescence negative periphery in newly diagnosed glioblastoma, was instead the exclusive pathway classified in the tumor core of recurrent glioblastoma. These results, preliminary obtained on sample pools, demonstrated the potential of cavitron ultrasonic sur.

摘要

本研究旨在借助5-氨基乙酰丙酸荧光,对新诊断和复发性胶质母细胞瘤的超声空化吸引液的蛋白质谱进行表征,比较不同的采集区域,即肿瘤核心和肿瘤周边。将样本汇集后,采用鸟枪法蛋白质组学方法通过液相色谱-质谱联用(LC-MS)进行一式三份分析。然后将鉴定出的蛋白质分组,以揭示肿瘤状态或肿瘤区域独有的和共有的元素,并进行基因本体分类和通路富集分析。采用无标记方法通过相对定量进一步研究不同区域共有的蛋白质,以揭示可能的表达差异。九种蛋白质,即微管蛋白2B链、CD59、远上游元件结合蛋白、CD44、组蛋白H1.4、钙调蛋白、骨桥蛋白、原肌球蛋白链和金属硫蛋白-2,在新诊断的胶质母细胞瘤核心相对于肿瘤周边有显著特征。考虑到肿瘤区域,包括核心和荧光阳性周边,丝氨酸甘氨酸生物合成、磷酸戊糖、5-羟色胺降解、嘌呤从头合成和亨廷顿病通路相对于参考人类基因组在统计学上有显著富集。荧光阴性区域与肿瘤区域共享几个蛋白质元素,这可能表明存在胶质母细胞瘤的病理特征而非正常脑实质。另一方面,其独有的蛋白质元素被认为代表健康区域,因此未表现出通路富集。与新诊断的胶质母细胞瘤相反,通路富集仅在复发性胶质母细胞瘤的健康区域被识别。在新诊断的胶质母细胞瘤中仅在荧光阴性周边分类的转化生长因子β(TGFβ)信号通路,在复发性胶质母细胞瘤的肿瘤核心中却是唯一分类的通路。这些在样本汇集上初步获得的结果证明了超声空化吸引术的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/7801f56dab33/cancers-13-00030-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/cf56ad9d48d0/cancers-13-00030-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/e4c6cff9d5ec/cancers-13-00030-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/5bd0e75c0a2f/cancers-13-00030-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/8c4229dacd87/cancers-13-00030-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/9f30b86929dd/cancers-13-00030-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/05bf5e57560a/cancers-13-00030-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/46ccd1581a41/cancers-13-00030-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/182f6a04db04/cancers-13-00030-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/d337b8930751/cancers-13-00030-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/3626318eea69/cancers-13-00030-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/b1a54fcbe6f5/cancers-13-00030-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/7801f56dab33/cancers-13-00030-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/cf56ad9d48d0/cancers-13-00030-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/e4c6cff9d5ec/cancers-13-00030-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/5bd0e75c0a2f/cancers-13-00030-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/8c4229dacd87/cancers-13-00030-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/9f30b86929dd/cancers-13-00030-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/05bf5e57560a/cancers-13-00030-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/46ccd1581a41/cancers-13-00030-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/182f6a04db04/cancers-13-00030-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/d337b8930751/cancers-13-00030-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/3626318eea69/cancers-13-00030-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/b1a54fcbe6f5/cancers-13-00030-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d4/7795841/7801f56dab33/cancers-13-00030-g012.jpg

相似文献

1
Glioblastoma CUSA Fluid Protein Profiling: A Comparative Investigation of the Core and Peripheral Tumor Zones.胶质母细胞瘤的CUSA液体蛋白质谱分析:肿瘤核心区与周边区的比较研究
Cancers (Basel). 2020 Dec 23;13(1):30. doi: 10.3390/cancers13010030.
2
Investigating Glioblastoma Multiforme Sub-Proteomes: A Computational Study of CUSA Fluid Proteomic Data.研究多形性胶质母细胞瘤亚蛋白质组:对CUSA流体蛋白质组数据的计算研究
Int J Mol Sci. 2022 Feb 12;23(4):2058. doi: 10.3390/ijms23042058.
3
Ependymoma Pediatric Brain Tumor Protein Fingerprinting by Integrated Mass Spectrometry Platforms: A Pilot Investigation.通过综合质谱平台进行小儿室管膜瘤脑肿瘤蛋白指纹图谱分析:一项初步研究。
Cancers (Basel). 2020 Mar 13;12(3):674. doi: 10.3390/cancers12030674.
4
Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.对新诊断的胶质母细胞瘤中不同 5-氨基乙酰丙酸诱导荧光水平的系统组织病理学分析。
J Neurosurg. 2018 Aug;129(2):341-353. doi: 10.3171/2017.4.JNS162991. Epub 2017 Oct 27.
5
Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.胶质母细胞瘤衍生的细胞外囊泡的综合蛋白质组分析确定了侵袭性更强疾病的标志物。
J Neurooncol. 2017 Jan;131(2):233-244. doi: 10.1007/s11060-016-2298-3. Epub 2016 Oct 21.
6
Immunocytochemical evaluation of central nervous system tumors obtained by the Cavitron ultrasonic surgical aspirator.对通过Cavitron超声手术吸引器获取的中枢神经系统肿瘤进行免疫细胞化学评估。
Diagn Cytopathol. 1990;6(5):308-12. doi: 10.1002/dc.2840060504.
7
The Invasive Region of Glioblastoma Defined by 5ALA Guided Surgery Has an Altered Cancer Stem Cell Marker Profile Compared to Central Tumour.5ALA 引导手术定义的胶质母细胞瘤侵袭区与中央肿瘤相比具有改变的癌症干细胞标志物特征。
Int J Mol Sci. 2017 Nov 18;18(11):2452. doi: 10.3390/ijms18112452.
8
3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells.3-溴丙酮酸处理诱导脑胶质瘤细胞代谢和应激相关途径的改变。
J Proteomics. 2017 Jan 30;152:329-338. doi: 10.1016/j.jprot.2016.11.013. Epub 2016 Nov 24.
9
Overexpression of protease-activated receptor type 1 (PAR-1) in glioblastoma multiforme WHO IV cells and blood vessels revealed by NCAM-assisted glioblastoma border labeling.通过NCAM辅助的多形性胶质母细胞瘤边界标记揭示多形性胶质母细胞瘤WHO IV级细胞和血管中1型蛋白酶激活受体(PAR-1)的过表达。
Neurol Res. 2014 Aug;36(8):709-21. doi: 10.1179/1743132813Y.0000000303. Epub 2014 Jan 29.
10
Combined Fluorescence Using 5-Aminolevulinic Acid and Fluorescein Sodium at Glioblastoma Border: Intraoperative Findings and Histopathologic Data About 3 Newly Diagnosed Consecutive Cases.5-氨基酮戊酸与荧光素钠联合荧光成像在胶质母细胞瘤边界的应用:3例连续新诊断病例的术中发现及组织病理学数据
World Neurosurg. 2019 Feb;122:e856-e863. doi: 10.1016/j.wneu.2018.10.163. Epub 2018 Nov 2.

引用本文的文献

1
Proteomic Analysis of the Low Molecular Mass Fraction of Newly Diagnosed and Recurrent Glioblastoma CUSA Fluid: A Pilot Investigation of the Peptidomic Profile.新诊断和复发性胶质母细胞瘤CUSA液低分子质量组分的蛋白质组学分析:肽组学特征的初步研究
Int J Mol Sci. 2025 Jun 24;26(13):6055. doi: 10.3390/ijms26136055.
2
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of surgery in the management of patients with diffuse low grade glioma: update.神经外科医师协会关于手术在弥漫性低级别胶质瘤患者管理中作用的系统评价及循证指南:更新版
J Neurooncol. 2025 Mar;172(1):99-152. doi: 10.1007/s11060-024-04871-4. Epub 2025 Jan 13.
3

本文引用的文献

1
Heterogeneity Matters: Different Regions of Glioblastoma Are Characterized by Distinctive Tumor-Supporting Pathways.异质性至关重要:胶质母细胞瘤的不同区域具有独特的肿瘤支持途径。
Cancers (Basel). 2020 Oct 13;12(10):2960. doi: 10.3390/cancers12102960.
2
Contrast enhanced ultrasound (CEUS) applications in neurosurgical and neurological settings - New scenarios for brain and spinal cord ultrasonography. A systematic review.对比增强超声(CEUS)在神经外科和神经科环境中的应用 - 脑和脊髓超声的新应用场景。系统综述。
Clin Neurol Neurosurg. 2020 Nov;198:106105. doi: 10.1016/j.clineuro.2020.106105. Epub 2020 Jul 24.
3
Proteomic Profiling of Pre- and Post-Surgery Saliva of Glioblastoma Patients: A Pilot Investigation.
胶质母细胞瘤患者手术前后唾液的蛋白质组学分析:一项初步研究。
Int J Mol Sci. 2024 Dec 3;25(23):12984. doi: 10.3390/ijms252312984.
4
Proteomics Studies on Extracellular Vesicles Derived from Glioblastoma: Where Do We Stand?基于神经胶质瘤细胞外囊泡的蛋白质组学研究:我们的研究现状如何?
Int J Mol Sci. 2024 Sep 10;25(18):9778. doi: 10.3390/ijms25189778.
5
Recurrent Glioblastoma: What Is the Route?复发性胶质母细胞瘤:其途径是什么?
Cancers (Basel). 2023 Mar 29;15(7):2028. doi: 10.3390/cancers15072028.
6
Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research.代谢组学和蛋白质组学在胶质母细胞瘤研究中的临床前和临床应用。
Int J Mol Sci. 2022 Dec 25;24(1):348. doi: 10.3390/ijms24010348.
7
Seizures in patients with IDH-mutated lower grade gliomas.伴有 IDH 突变的低级别胶质瘤患者的癫痫发作。
J Neurooncol. 2022 Nov;160(2):403-411. doi: 10.1007/s11060-022-04158-6. Epub 2022 Oct 18.
8
Investigating Glioblastoma Multiforme Sub-Proteomes: A Computational Study of CUSA Fluid Proteomic Data.研究多形性胶质母细胞瘤亚蛋白质组:对CUSA流体蛋白质组数据的计算研究
Int J Mol Sci. 2022 Feb 12;23(4):2058. doi: 10.3390/ijms23042058.
9
The Big Picture of Glioblastoma Malignancy: A Meta-Analysis of Glioblastoma Proteomics to Identify Altered Biological Pathways.胶质母细胞瘤恶性肿瘤全景:胶质母细胞瘤蛋白质组学的荟萃分析以识别改变的生物学途径
ACS Omega. 2021 Sep 14;6(38):24535-24544. doi: 10.1021/acsomega.1c02991. eCollection 2021 Sep 28.
Breaking through the glioblastoma micro-environment via extracellular vesicles.
通过细胞外囊泡突破脑胶质瘤微环境。
Oncogene. 2020 Jun;39(23):4477-4490. doi: 10.1038/s41388-020-1308-2. Epub 2020 May 4.
4
5-Aminolevulinic Acid and Contrast-Enhanced Ultrasound: The Combination of the Two Techniques to Optimize the Extent of Resection in Glioblastoma Surgery.5-氨基酮戊酸与超声造影:两种技术联合优化脑胶质瘤手术切除范围
Neurosurgery. 2020 Jun 1;86(6):E529-E540. doi: 10.1093/neuros/nyaa037.
5
Extracellular Vesicles in Glioblastoma Tumor Microenvironment.脑胶质瘤肿瘤微环境中的细胞外囊泡。
Front Immunol. 2020 Jan 21;10:3137. doi: 10.3389/fimmu.2019.03137. eCollection 2019.
6
Glioblastoma: from volumetric analysis to molecular predictors.胶质母细胞瘤:从体积分析到分子预测因子。
J Neurosurg Sci. 2022 Jun;66(3):173-186. doi: 10.23736/S0390-5616.20.04850-X. Epub 2020 Feb 4.
7
State of the art of fluorescence guided techniques in neurosurgery.神经外科荧光引导技术的现状。
J Neurosurg Sci. 2019 Dec;63(6):619-624. doi: 10.23736/S0390-5616.19.04854-9.
8
Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme.锌指蛋白 22(ZYX)促进侵袭,是多形性胶质母细胞瘤侵袭表型的生物标志物。
Lab Invest. 2020 Jun;100(6):812-823. doi: 10.1038/s41374-019-0368-9. Epub 2020 Jan 16.
9
Extracellular vesicles and their role in glioblastoma.细胞外囊泡及其在胶质母细胞瘤中的作用。
Crit Rev Clin Lab Sci. 2019 Dec 22;57(4):227-252. doi: 10.1080/10408363.2019.1700208.
10
Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics.当前和未来的胶质母细胞瘤诊断和预后趋势:从分子生物学到蛋白质组学。
Cells. 2019 Aug 9;8(8):863. doi: 10.3390/cells8080863.